Video Game Play to Alleviate Adolescent Anxiety

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age11-15
SponsorSchool of Health Sciences Geneva

About this trial

Adolescence is a critical period for the onset and maintenance of anxiety disorders, which raises the importance of intervening early; one possibility of doing so is via digital interventions. At least two lines of research have been explored in the past years in this area. First, studies have tested the anxiolytic effects of casual video games, hypothesizing that, through the induction of flow, these games can effectively distract individuals from anxiety-related thoughts and feelings. Second, the bidirectional link between poor attentional control and higher anxiety has led to the design of novel interventions aiming to improve attentional control such as working memory training studies. Importantly, action video games, classified as a distinct gaming genre, have been shown to enhance attentional control. In this study, we aim to compare the effects of action video game play and casual game play to a no-training group, assessing their potential to alleviate anxiety when delivered entirely online. The goal of this three- arms randomized controlled trial is to evaluate the feasibility of a 6-week video game training intervention to reduce adolescent anxiety-related symptoms. We will also examine the efficacy of the proposed treatment when entirely deployed at adolescents' home.

Eligibility criteria

Qualifiers

Adolescents aged 11-15 years

High-anxious score from the 41 items SCARED-Parent version (i.e. total score equal or above 17)

Access to a computer (at least Windows 7 or Mac OSX) at home and a reliable internet connection

Disqualifiers

DSM diagnoses of Bipolar, Psychosis, Autism Spectrum Disorder, present or past.

Neurological injury (i.e. head injury)

Currently enrolled in another cognitive training intervention

Trial design

Treatments tested in this trial

  • Eco-Rescue
  • Bejelewed 3

Treatment groups

150 Participants
are divided into 3 treatment groups

Locations

2
Israel
University of Haifa Haifa Israel
Switzerland
University of Geneva1202, GenevaCanton of Geneva, Switzerland

Sponsors and collaborators

School of Health Sciences Geneva

Lead sponsor

University of Geneva, Switzerland

Collaborator

University of Haifa

Collaborator

Swiss National Science Foundation

Collaborator